AACR Journals to Publish Impactful Articles Concurrent with Presentation at AACR Annual Meeting 2023
ORLANDO, Fla. – More than 30 articles of advances in cancer research will be presented at the AACR Annual...
Loading...
Original COVID-19 Booster Vaccines May Offer Limited Protection Against Omicron Variants in Patients with Blood Cancer
Two studies provide evidence of reduced booster efficacy in this high-risk population PHILADELPHIA – Compared with healthy individuals, patients...
Research Published in AACR Journal and Presented at ASH Identifies Potential Approach to Mitigate CAR T-cell Therapy Toxicity
Suppressing IFNγ could help prevent cytokine release syndrome without impacting CAR T-cell therapy efficacy PHILADELPHIA – Blood Cancer Discovery,...
AACR Journal Features Two Studies on COVID-19 Vaccine Efficacy in Patients with Blood Cancers
PHILADELPHIA – Blood Cancer Discovery, a journal of the American Association for Cancer Research, today published two articles investigating...
AACR Journal Cancer Discovery Celebrates 10th Anniversary with Virtual Symposium Highlighting Emerging Areas of Cancer Research
Complimentary registration is available to credentialed news media WHAT: Later this month, the American Association for Cancer Research (AACR)...
AACR Journals to Publish Two Articles Concurrent with Presentation at ASH
PHILADELPHIA – Cancer Discovery and Blood Cancer Discovery, journals of the American Association for Cancer Research, will both publish...
AACR Journals Feature New Data on COVID-19 Outcomes in Patients with Cancer
PHILADELPHIA – Cancer Discovery and Blood Cancer Discovery, journals of the American Association for Cancer Research, recently published two...
BRAF Inhibitor Shows Promising Results in Pediatric Patients with Low-Grade Glioma
PHILADELPHIA — Dabrafenib (Tafinlar), a BRAF inhibitor approved to treat certain types of adult melanoma, showed activity in pediatric...